Trends in oesophago-gastric cancer incidence in Spain: Analysis by subsite and histology

Annals of Oncology

Volumn 21, Issue SUPPL.3, 2010, Pages

  Aragones N ^a,g   Izarzugaza, M I ^b,g   Ramos, M ^c   Chirlaque, M D ^d,g   Almar, E ^e   Martinez C ^f   Aleman A ^h   Arguelles, M ⁱ   Cardo X ^j   Cervantes, M ^k   Jimenez R ^e   Martos, C ^l   Moreno Iribas, C ^m   Perez Gomez B ^a   Perucha, J ⁿ  

^a CARLOS III INSTITUTE OF HEALTH   (Spain)

^b Basque Country Regional Authority   (Spain)

^c Mallorca Cancer Registry   (Spain)

^d Health Authority   (Spain)

^e Health and Social Welfare Authority   (Spain)

^f ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^g CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^h Canary Islands Cancer Registry   (Spain)

ⁱ Health and Medical Services Authority   (Spain)

^j INSTITUT D INVESTIGACIÓ SANITÀRIA PERE VIRGILI IISPV   (Spain)

^k DEPARTMENT OF HEALTH   (Spain)

^l INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^m INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

ⁿ La Rioja Cancer Registry   (Spain)

more..

Author keywords

Adenocarcinoma; Gastric neoplasm; Gastro oesophageal junction; Incidence; Oesophageal neoplasm; Population based; Registry; Trends

Indexed keywords

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORPHOLOGY; CANCER REGISTRY; CANCER RISK; CHILD; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SPAIN; STOMACH CANCER; TREND STUDY; AGE; CLASSIFICATION; COMPARATIVE STUDY; ESOPHAGUS TUMOR; INCIDENCE; MIDDLE AGED; PATHOLOGY; REGISTER; SEX DIFFERENCE; STOMACH TUMOR;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; REGISTRIES; SEX FACTORS; SPAIN; STOMACH NEOPLASMS;

EID: 79952116465     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq083     Document Type: Article

References (35)

1. López-Abente G, Pollán M, Aragonés N et al. La situación del cáncer en Españ a. Madrid, Spain: Ministerio de Sanidad y Consumo 2005.
2. Berrino F, De Angelis R, Sant M et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 2007; 8: 773-783.
3. Bosetti C, Levi F, Ferlay J et al. Trends in oesophageal cancer incidence and mortality in Europe. Int J Cancer 2008; 122: 1118-1129.
4. La Vecchia C, Lucchini F, Negri E et al. Trends of cancer mortality in Europe, 1955-1989: I, digestive sites. Eur J Cancer 1992; 28: 132-235.
5. Aragones N, Pollan M, Rodero I, Lopez-Abente G. Gastric cancer in the European Union (1968-1992). mortality trends and cohort effect. Ann Epidemiol 1997; 7: 294-303.
6. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83: 2049-2053.
7. Vizcaino AP, Moreno V, Lambert R, Parkin DM. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int J Cancer 2002; 99: 860-868.
8. Botterweck AA, Schouten LJ, Volovics A et al. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000; 29: 645-654.
9. Brown LM, Devesa SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am 2002; 11: 235-256.
10. Sihvo EI, Salminen JT, Ramo OJ, Salo JA. The epidemiology of oesophageal adenocarcinoma: has the cancer of gastric cardia an influence on the rising incidence of oesophageal adenocarcinoma? Scand J Gastroenterol 2000; 35: 1082-1086.
11. Steevens J, Botterweck AA, Dirx MJ et al. Trends in incidence of oesophageal and stomach cancer subtypes in Europe. Eur J Gastroenterol Hepatol 2009; May 26 [Epub ahead of print].
12. McCullagh P, Nelder JA. Generalized Linear Models, 2nd edition. London, UK: Chapman & Hall 2009.
13. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335-351.
14. Pastor-Barriuso R, Guallar E, Coresh J. Transition models for change-point estimation in logistic regression. Stat Med 2003; 22: 1141-1162.
15. Pollan M, Pastor-Barriuso R, Ardanaz E et al. Recent decline in breast cancer incidence in Spain linked to screening saturation. J Natl Cancer Inst 2009; 101: 1584-1591.
16. Curado MP, Edwards B, Shin HR et al. Cancer Incidence in Five Continents., Vol. IX. Lyon, France: IARC 2009.
17. Rudiger SJ, Feith M, Werner M, Stein HJ. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 2000; 232: 353-361.
18. Izarzugaza I, Ardanaz E, Chirlaque MD et al. Tobacco-related tumours of the lung, bladder and larynx: changes in Spain. Ann Oncol 2010; 21(Suppl 3): iii52-iii60.
19. Lord RV, Law MG, Ward RL et al. Rising incidence of oesophageal adenocarcinoma in men in Australia. J Gastroenterol Hepatol 1998; 13: 356-362.
20. Powell J, McConkey CC, Gillison EW, Spychal RT. Continuing rising trend in oesophageal adenocarcinoma. Int J Cancer 2002; 102: 422-427.
21. Schmassmann A, Oldendorf MG, Gebbers JO. Changing incidence of gastric and oesophageal cancer subtypes in central Switzerland between 1982 and 2007. Eur J Epidemiol 2009; 24: 603-609.
22. Newnham A, Quinn MJ, Babb P et al. Trends in the subsite and morphology of oesophageal and gastric cancer in England and Wales 1971-1998. Aliment Pharmacol Ther 2003; 17: 665-676.
23. Ekstrom AM, Signorello LB, Hansson LE et al. Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst 1999; 91: 786-790.
24. Spechler SJ, Dixon MF, Genta R. Adenocarcinoma of the oesophago-gastric junction. In Hamilton SR, Aaltonen LA (eds): Pathology and Genetics of Tumours of the Digestive System. Lyon, France: IARC-WHO 2000; 31-36.
25. Desoubeaux N, Le Prieur A, Launoy G et al. Recent time trends in cancer of the oesophagus and gastric cardia in the region of Calvados in France, 1978-1995: a population based study. Eur J Cancer Prev 1999; 8: 479-486.
26. Lindblad M, Ye W, Lindgren A, Lagergren J. Disparities in the classification of esophageal and cardia adenocarcinomas and their influence on reported incidence rates. Ann Surg 2006; 243: 479-485.
27. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005; 97: 142-146.
28. Wijnhoven BP, Louwman MW, Tilanus HW, Coebergh JW. Increased incidence of adenocarcinomas at the gastro-oesophageal junction in Dutch males since the 1990s. Eur J Gastroenterol Hepatol 2002; 14: 115-122.
29. Dolan K, Sutton R, Walker SJ et al. New classification of oesophageal and gastric carcinomas derived from changing patterns in epidemiology. Br J Cancer 1999; 80: 834-842.
30. Rusch VW. Are cancers of the esophagus, gastroesophageal junction, and cardia one disease, two, or several? Semin Oncol 2004; 31: 444-449.
31. Corley DA, Buffler PA. Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database. Int J Epidemiol 2001; 30: 1415-1425.
32. Brewster DH, Fraser LA, McKinney PA, Black RJ. Socioeconomic status and risk of adenocarcinoma of the oesophagus and cancer of the gastric cardia in Scotland. Br J Cancer 2000; 83: 387-390.
33. Orengo MA, Casella C, Fontana V et al. Trends in incidence rates of oesophagus and gastric cancer in Italy by subsite and histology, 1986-1997. Eur J Gastroenterol Hepatol 2006; 18: 739-746.
34. Ekstrom AM, Hansson LE, Signorello LB et al. Decreasing incidence of both major histologic subtypes of gastric adenocarcinoma-a population-based study in Sweden. Br J Cancer 2000; 83: 391-396.
35. Engel LS, Chow WH, Vaughan TL et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 2003; 95: 1404-1413.